Loading asset research
Aardvark Therapeutics Inc. Common Stock
AARDNasdaq · USD · StocksQuote as of · Exchange session not verified$5.13
+2.40%
Today
AARD
Loading 1D prices…
Market cap
$112.3M
Volume
276.6K
52w high
$17.9452w low
$3.35Company profile
Aardvark Therapeutics Inc. Common Stock
Aardvark Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing small-molecule therapeutics to activate innate homeostatic pathways for the treatment of metabolic diseases. Aardvark Therapeutics, Inc. was incorporated in 2017 and is headquartered in San Diego, California.
Sector
Health Care
Industry
Pharmaceutical Preparations
Exchange
Nasdaq
Display currency
USD
Location
San Diego, CA, United States
Employees
28
Fiscal year end
1231
CIK
1774857
Session & valuation
Open$5.11
Previous close$5.01
Day high$5.54
Day low$4.97
30-day avg. volume135.1K
Outstanding shares21.9M
Diluted EPS-$2.93
Latest annual period
P/E (trailing)-1.75
P/E (forward)-1.84
Price / book1.50
Beta—
Dividend yield—
Deterministic peer set
Companies with SEC SIC 2834
Exact regulatory industry matches, ranked by nearest market capitalization.
| Company | Market cap | Revenue | Net margin | Diluted EPS | Today | Consensus |
|---|---|---|---|---|---|---|
| QUCYQuantum Cyber N.V. Ordinary Shares | $112.7M | $537.1K | -3018.31% | -$2.70 | -1.46% | Hold |
| GNLXGenelux Corporation Common Stock | $112.7M | $8K | -401812.50% | -$0.86 | +0.40% | Buy |
| RANIRani Therapeutics Holdings Inc. Class A Common Stock | $118.4M | $1.6M | -1817.09% | -$0.45 | +2.55% | Buy |
| RFLRafael Holdings Inc. Class B Common Stock | $118.6M | $630K | -3247.46% | -$0.40 | -3.39% | Unrated |
| NTHINeOnc Technologies Holdings Inc. Common Stock | $106M | $40K | -155404.38% | -$3.20 | +0.55% | Buy |